Ultime notizie per Nomura Holdings (NYSE:NMR) Azioni

Nomura Holdings

Nomura Holdings Inc is a financial services group in Japan and operates offices in countries and regions worldwide including Japan, the U.S., the U.K., Singapore, and the Hong Kong Special Administrative Region ("Hong Kong") through its subsidiaries. The company's clients include individuals, corporations, financial institutions, governments, and governmental agencies. The company's business consists of Wealth Management*, Investment Management, and Wholesale. The company generates the majority of its revenue from the wholesale segment. The Wholesale Division consists of two businesses, Global Markets, which is mainly engaged in the trading, sales, and structuring of financial products, and Investment Banking which is engaged in advisory, financing, and solutions businesses.

Nomura Holdings Inc ADR American Depositary Shares

Nomura Holdings Inc

Numeraire - United States Dollar

Neumora Therapeutics, Inc. - Common Stock

Neumora Therapeutics Inc

NEMAURA MEDICAL INC by Nemaura Medical, Inc.

Nemaura Medical Inc

NAMIBIA CRITICAL METALS by Namibia Critical Metals Inc.

Namibia Critical Metals Inc

Newmark Group, Inc. - Class A Common Stock

Newmark Group Inc

Numeral Ltd

NATIONAL MILK RECORDS PLC by National Milk Records Plc.

NAMURA SHIPBUILD CO ORD by Namura Shipbuilding Co. Ltd.

Namura Shipbuilding Co Ltd

Last week, instant Experts of the Internet took a few minutes off their duties as Global Trade and Monetary Policy Experts to share their insights on the information gleaned from the latest round of 13F filings at the SEC.
The Clickbait Delivery Vehicles masquerading as financial media took a hot second to refrain from delivering forecasts of the financial collapse of the Western world and almost guaranteed strategies for becoming fabulously wealthy by next Tuesday to do the same.
Although more than 6,000 or so money managers, institutions, and hedge funds have over $100 million in assets and are required to file a list of their holdings at the end of every quarter, the media and the Instant Experts will focus on about ten of the best-known investors to deliver their life-changing advice.
I will read the filings from Warren Buffett, Carl Ichan, Seth Klarman and other well-known and ridiculously successful investors to see what they are up to.
I might even build a watch list of a few ideas to put on a market crash watch list.
However, making a practice to steal the same ideas that a few million other people will also be buying creates no edge and little chance of the ever-elusive excess profits which we seek.
I have been perusing 13F filings since the late 1980s. Back in the pre-Internet days, we had to wait until the end of the day (or the weekend) and use the Quotron machine and print the filings out on the dot matrix printers in the back room of the office.
Using them during the day was out of the question as they took forever to print.
We would then go through the filings and compare them to last quarter, using a yellow highlighter to mark changes.
It was a tad tedious but very few people were doing it, and it was wildly profitable to steal ideas from the best investors on the planet.
As time went on, it became easier to access and compare the information and develop ideas.
While one would think that would mean it became more difficult to profit from stock piracy, that never happened.
The same technology that made accessing information easier led to the rise of the instant expert and the soundbite.
You could have made a lot of money over the last couple of decades tracking the holdings of Donald Smith and Company.
The firm is way off the radar screen but has used a deep value investment approach to soundly beat the indexes.
It took more work than logging onto social media or watching market wrap soundbites, but it has paid off with market-beating returns.
Here are the top five stocks the firm bought in the first quarter of the year:
Park Hotels &amp; Resorts (Ticker: PK) is a publicly traded lodging REIT focused on owning and operating high-quality hotels and resorts primarily in major U.S. markets. The portfolio is heavily weighted toward urban full-service hotels and is currently undergoing a strategic repositioning to improve profitability following post-pandemic demand shifts.
The shares trade at 62% of book value.
Harley-Davidson is an iconic American motorcycle manufacturer known for heavyweight touring and cruiser bikes, with operations split between motorcycles and financial services. The company is focused on revitalizing its brand through premium product offerings and global expansion, while managing declining U.S. ridership demographics.
The stock trades at 93% of book value.
Eldorado Gold (Ticker: EGO) is a Canadian-based mid-tier gold producer with mining, development, and exploration operations in Turkey, Canada, and Greece. The company emphasizes long-life assets with low all-in sustaining costs and maintains a conservative balance sheet to fund organic growth.
The shares trade hands at just 90% of asset value currently.
Hudbay Minerals (Ticker: HBM) is a diversified Canadian mining company primarily engaged in the production of copper, zinc, gold, and silver through assets in North and South America. The firm recently expanded copper production capacity in Arizona and remains highly leveraged to global base metal demand.
The stock trades at 1.2 times book, so you might want to wait for a pullback to be a buyer.
Nomura Holdings (Ticker: NMR) is Japan&#8217;s largest investment bank and brokerage, offering global financial services including asset management, trading, and investment banking. While deeply rooted in the Japanese market, Nomura has sought international growth, particularly in the U.S. and Europe, amid a challenging interest rate and competitive environment.
I am a huge Japan bull and have recommended Nomura shares on several other occasions. The stock is trading at just 75% of book value.
If you want something with a little more zing to it, consider focusing your idea piracy on the portfolio of Shannon Fund Partners.
Shannon was set up by investor Spencer Waxman back in 2003 to invest in high tech stocks. Waxman and his team look for mispriced growth opportunities and disruptive trends within the technology, media, and telecommunications sectors.
Based on their track record, they are really good at it as they have averaged 20% a year over the last decade.
Shannon Fund&#8217;s top five purchases in the quarter were a little more adventurous.
Qorvo (Ticker: QRVO) makes the chips that help your phone talk to the cell tower and your car talk to, well, everything else. Business has been steady, and they just dropped a solid earnings report showing strength in mobile and defense. With a recent acquisition (Anokiwave) boosting their 5G and military offerings, there&#8217;s a good chance this name keeps climbing the radar of long-term growth investors.
Elastic (Ticker: ESTC) is the company behind Elasticsearch — the kind of search tech that powers apps, websites, and cybersecurity tools. They&#8217;re shifting more of their revenue into the cloud, and that part of the business is growing like a weed, now making up more than half of subscriptions. With AI and observability tools becoming more essential, Elastic has a clear runway to keep expanding in the enterprise space.
Wix (Ticker: WIX) is what your cousin used to build their food truck website, and what marketing teams now use to spin up slick pages without writing code. Revenue is growing in the double digits, and their Partners business (think: pros who build sites for others) is leading the charge. Add in a dose of AI, and Wix looks like it&#8217;s quietly becoming the toolkit of choice for the modern web.
Zoom (Ticker: ZM) isn&#8217;t just the pandemic darling anymore, it&#8217;s trying to grow up into a full communications platform for work. Enterprise sales are driving modest growth now, and Zoom is betting big on AI collaboration tools to stand out in a crowded space. It&#8217;s no longer a hypergrowth story, but it&#8217;s a business with staying power and an evolving product line.
Tower (Ticker: TSEM) makes the behind-the-scenes chips that go into everything from industrial equipment to wireless gear. The last quarter showed decent revenue growth, and management sees steady improvement through the rest of the year. It&#8217;s not flashy, but Tower is a steady operator in a part of the chip world that doesn&#8217;t get enough love.
There is a lot of money to be made stealing ideas from the best money managers and hedge fund types if you avoid the headlines and focus on the under-the-radar folks putting up big numbers.

Opinion

ESTC

QRVO

TSEM

Under the Radar: Quiet Portfolios, Loud Returns

WIIM

ALLY

ARES

FITB

HBAN

NTRS

SCHW

SPGI

TROW

Shares of banks and financial services stocks are higher after the US and China agreed to a temporary reduction in most tariffs on each other's goods. A reduction in tariffs could alleviate macro uncertainty in the lending and deal environment.

Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) reported quarterly earnings of $0.15 per share. This is a 25 percent increase over earnings of $0.12 per share from the same period last year. The company reported $2.97 billion in sales this quarter. This is a 1.00 percent decrease over sales of $3.00 billion the same period last year.

Earnings

News

Nomura Holdings Q4 EPS $0.15 Up From $0.12 YoY, Sales $2.97B Down From $3.00B YoY

On Tuesday, Nomura Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) disclosed a definitive agreement to acquire Macquarie Group, Ltd.&#8217;s (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MCQEF#OTC">MCQEF</a>) public asset management operations in the U.S. and Europe in an <a target="_blank" href="https://www.benzinga.com/topic/why-its-moving" rel="noreferrer noopener">all-cash deal valued at $1.8 billion</a>.
The deal includes around $180 billion in assets under management from retail <a target="_blank" href="https://www.nomuraholdings.com/news/nr/holdings/20250422/20250422.html" rel="noreferrer noopener">and</a> institutional clients, spanning equity, fixed income, and multi-asset strategies.
The transaction is expected to close by the year-end, pending regulatory approvals and customary closing conditions.
This acquisition is projected to enhance Nomura&#8217;s global reach and capabilities of its Investment Management Division, which currently oversees approximately $590 billion in assets.
Following the deal&#8217;s completion, Nomura&#8217;s total assets under management are expected to rise to roughly $770 billion, with over 35% of those assets <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">managed for clients outside Japan</a>.
The transaction will also establish the company&#8217;s substantial operational base in Philadelphia.
Kentaro Okuda, Nomura President and Group CEO, said &#8220;This acquisition will align with our 2030 global growth and diversification ambitions to invest in stable, high margin businesses,&#8221;
As of December 31, 2024, cash and cash deposits stood <a target="_blank" href="https://www.nomuraholdings.com/investor/summary/financial/data/2025_3q_pres.pdf" rel="noreferrer noopener">at </a>5.575 billion Yen.
Price Action: NMR shares are up 2.75% at $5.600&nbsp;at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/upgrades/25/04/44935871/self-storage-reits-score-upgrade-from-bofa-analyst-8-decline-in-new-construction-helps-sector" target="_blank" rel="noreferrer noopener">Self-Storage REITs Score Upgrade From BofA Analyst: 8% Decline In New Construction Helps Sector</a></li>
</ul>
Photo via Shutterstock

Equities

Large Cap

MCQEF

Nomura Eyes Global Growth With $1.8 Billion Macquarie Asset Buyout, Targets Growing AUM To $770 Billion

Reported Earlier, Nomura Plans To Fully Acquire Stock Of Three Companies That Operate Macquarie's U.S. And European Public Asset Management Business For An All-cash Price Of $1.8B

CRBG

ENVA

FRHC

HLNE

Janus Henderson Group plc Ordinary Shares

LPLA

PIPR

SNEX

VCTR

Shares of companies within the broader financial sector are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

DGICB

PMAX

ZBAO

Shares of companies within the broader financial sector are trading lower in response to President Trump's sweeping Liberation tariffs and retaliatory responses. The sector is now facing greater macroeconomic uncertainty and recession fears.

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BRDG

EMCG

FUTU

HOOD

IBKR

LPRO

MKTW

NDAQ

PowerShares Exchange Traded Fund Trust Dynamic Mid Cap Value Portfolio

STEP

Shares of capital market companies are trading lower as markets react to President Trump's announcement of sweeping tariffs.

BBDO

BBVA

BSBR

CNCK

GDOT

HSBC

INTR

ITUB

JFIN

LMND

MUFG

QFIN

ROOT

SMFG

SOFI

TIGR

Shares of banks and financial services stocks are trading lower following greater-than-expected inflation data measured through the PCE price index for February, while personal spending missed estimates. Additionally, recent tariff announcements may be weighing on equities.

CNFR

HRTG

Shares of banks and financial services stocks are trading higher amid an overall market rebound following recent weakness.

Nomura Holdings shares are trading higher following Q3 financial results.

Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) reported quarterly earnings of $0.22 per share which met the analyst consensus estimate. This is a 100 percent increase over earnings of $0.11 per share from the same period last year. The company reported $3.30 billion in sales this quarter. This is a 21.66 percent increase over sales of $2.71 billion the same period last year.

Nomura Holdings Q3 EPS USD$0.22, Inline, Sales USD $3.30B Up From USD $2.71B YoY

ALGN

AMSC

AOSL

APPS

ARAY

ARCC

ASGN

ASYS

AZTA

BARK

BLBD

CENT

CENTA

CMRE

CNMD

CNXN

COHR

CPAY

CPRI

CRTO

CSGS

CTSH

CTVA

DGII

DLHC

ENSG

EQNR

EZPW

FORM

GEOS

HOLX

KMPR

LFVN

LSAK

LUCK

LVWR

MSTR

MTRX

MUSA

NOTV

NTGR

NVST

NWSA

ODFL

ORLY

PAHC

PFGC

Earnings Scheduled For February 5, 2025

It is all true.
The market is priced at ridiculous levels.
The current multiples of earnings, cash flow, assets, and dividends of the S&amp;P 500 (Ticker: SPY) imply that we live in a perfect world and perfection will continue to grow at a double-digit rate.
We do not live in a perfect world.
The bond market, usually the far brighter and less emotional market, has been showing great concern and a smudge of outright fear in recent weeks. It has reentered a downtrend even as stocks went higher.
Should we just sell and hide under a rock on top of a mountain somewhere until the headlines improve?
Probably not.
If we have learned nothing else, it is that markets can remain irrational, unrealistic, and overpriced for a very long time.
What we can do is become cautious.
Avoid companies where insiders are selling as the price declines.
Avoid stocks that are being sold by smart money investors with outstanding track records.
Flipping that over, if you are looking to put money to work, look for companies where insiders are making large open-market purchases of shares of the companies they manage.
Look for companies where investors with great track records are stepping up and establishing new company positions.
I recently sat down to review institutional buying and selling activity, and a couple of purchases caught my eye.
One such smart money buy was a biotech company.
Let me be upfront and say that I know nothing about biotechnology.
I am not a doctor, I have never played a doctor on television, and I generally avoid small-cap biotech stocks because that is where money goes to die.
There have been a handful of exceptions over the years, and they were all the result of noticing that a very smart, very successful investor had bought a lot of stock.
I noticed that Harris Kupperman of Praetorian Capital had purchased a 5.5% stake in Immune Bio (Ticker: INMB).
Kupperman, or JKuppy as he prefers to be called apparently, is not everyone&#8217;s cup of tea.
He can come across as brash, opinionated, and a tad arrogant.
He runs part of his fund in deep-value stocks and the other half in special situations.
It is almost like looking in a personality mirror.
He is also very good at what he does.
Kupperman runs his fund to do okay in what he calls standard years and to really push the edge when he feels he has uncovered opportunities in deeply undervalued markets and sectors.
It is working.
Since 2019, his fund is up a little over 700%.
Immune Bio is working on developing drugs using its core research that could help treat depression and Alzheimer&#8217;s.
Both are massive markets that could lead to substantial partnership opportunities or licensing deals for a company that progresses in developing a successful drug.
The folks at Praetorian are not the only ones excited about the stock. Raymond James analyst Gary Nachman recently wrote a favorable report with an $18 price target for shares of Immune Bio.
That is almost three times the current stock price.
The true test of another intelligence is how much they agree with me, and a closer peek into Praetorian&#8217;s portfolio at the end of the third quarter shows that he bought shares of one of my favorite Japanese firms, Nomura (Ticker: NMR).
Nomura has had one of those years that just naturally attracts my attention.
One staffer tried to manipulate the bond market, and the firm had to pay a fine and temporarily lost its status as a primary dealer.
Then, a Nomura staffer was arrested for attempting to murder an elderly client.
These are not the kind of headlines that attract enthusiastic buyers of your stock.
None of this impacts a firm of Nomura&#8217;s size, but it creates a cloud around the stock that creates buying opportunities.
The scandals have partially masked that business at Nomura is pretty good. Revenues are rising, and profits more than doubled, as the company reported its largest profits in four years.
The company is buying back stock and paying a cash dividend of 4.3%, rewarding shareholders with its excess cash.
The company is increasing its presence outside of Asia, focusing on wealthy markets like the Americas, India and the Middle East. Early results are promising, with solid gains in the number of customers for both wealth management and investment banking in these markets.
In spite of the strong results and positive outlook, the stock is trading at just 82% of tangible book value and less than ten times earnings.
These are uncertain times in financial markets.
There are as many possible outcomes as there are questions about what lies ahead in 2025.
Avoiding stocks where insiders and the smart money are selling and accumulating the ones they are buying can help us navigate turbulent waters profitably.

INMB

C-Suite Buy of the Week: Executive Moves from Biotech to Banking

Archegos Capital Management founder Bill Hwang was sentenced on Wednesday to 18 years in prison for fraud and market manipulation tied to the fund's <a href="https://www.benzinga.com/news/24/05/38718096/bill-hwangs-trial-begins-over-archegos-fund-collapse-what-to-expect">dramatic collapse in 2021.&nbsp;</a>
The Details: Hwang was sentenced by U.S. District Judge Alvin Hellerstein in New York to slightly less time than the 21 years prosecutors had sought in the case. 
Hwang's lawyers had asked that he be given no prison time at all and Hwang asked the judge on Wednesday to impose a sentence that would allow him to continue to serve society. He also said that he felt "deep pain" about what happened at Archegos, according to a Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-11-20/archegos-founder-bill-hwang-sentenced-to-18-years-in-prison?sref=TBDibEcD">report.</a>
Read More: <a href="https://www.benzinga.com/etfs/24/11/42044642/trump-appears-frustrated-as-elon-musk-chimes-in-on-treasury-secretary-adds-more-names-to-a-list-of-potential-picks">Trump Appears &#8216;Frustrated&#8217; As Elon Musk Chimes In On Treasury Secretary, Adds More Names To Short List&nbsp;</a>
Hellerstein said Hwang's request for no jail time was "utterly ridiculous" considering the amount of money involved. 
"The amount of losses that were caused by your conduct are larger than any amount of losses I've deal with as a judge," Hellerstein said.
The judge also compared Hwang to FTX founder Sam Bankman-Fried, who received a 25-year sentence for fraud.
"What was worse? Mr. Bankman-Fried's fraud or Mr. Hwang's fraud?" Hellerstein asked.
The jury found that Hwang directed Archegos staff to relay that the firm had large positions in companies such as Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>). Archegos actually invested heavily in a small group of stocks that could be more easily manipulated. 
The collapse at Archegos contributed <a href="https://www.benzinga.com/news/22/11/29835374/troubled-lender-credit-suisse-flags-massive-loss-for-q4-as-it-speeds-up-turnaround-plans">to the demise </a>of Credit Suisse Group AG and rippled through Wall Street causing significant losses at Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), UBS Group AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBS#NYSE">UBS</a>), Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) and other banks.
Former Archegos CFO Patrick Halligan was convicted alongside Hwang earlier in 2024 and will be sentenced separately in January.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/41949068/bitcoin-could-reach-1-million-by-2037-economist-says-buy-of-a-lifetime-opportunity">Bitcoin Could Reach $1 Million By 2037, Economist Says: &#8216;Buy Of A Lifetime&#8217; Opportunity</a></li>
</ul>
Photo: Shutterstock

Legal

Global

General

AAPL

MSFT

Hedge Funder Linked To Credit Suisse Collapse Gets 18 Year Prison Sentence For Fraud, Market Manipulation

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Tuesday.
Shares of Emerson Electric Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) rose sharply during Monday's session after the company reported better-than-expected fourth-quarter financial results and issued FY25 adjusted EPS guidance above estimates. Also, the company announced it increased return of capital to shareholders with plans to repurchase <a href="https://www.benzinga.com/news/earnings/24/11/41748679/emerson-electric-gains-on-q4-earnings-beat-and-fy25-growth-forecast-eyes-aspentech-buyout">approximately $2B in FY25.</a>
Net sales growth of 13% year over year to $4.62 billion, beating the consensus of $4.57 billion. Underlying sales were up 4%, and underlying orders increased by 2% in the quarter. Adjusted EPS improved 15% to $1.48, beating the consensus of $1.47.
Emerson Electric shares jumped 6.6% to $117.01 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Vimeo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) shares jumped 42.7% to $6.86 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter sales guidance above estimates.</li>
<li>Gogo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGO#NASDAQ">GOGO</a>) gained 29.3% to $8.47 after the company reported better-than-expected third-quarter financial results.</li>
<li>Astera Labs Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) rose 29.1% to $90.14 after the company reported better-than-expected third-quarter EPS and sales.</li>
<li>Aris Water Solutions Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARIS#NYSE">ARIS</a>) gained 25.8% to $20.84 following strong quarterly results.</li>
<li>Palantir Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) gained 22.4% to $50.70 after the company reported better-than-expected third-quarter financial results and issued guidance above consensus estimates.</li>
<li>UFP Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFPT#NASDAQ">UFPT</a>) rose 20.7% to $335.00 after the company reported better-than-expected third-quarter financial results.</li>
<li>Lindblad Expeditions Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIND#NASDAQ">LIND</a>) gained 20.6% to $11.28 after the company reported better-than-expected third-quarter financial results.</li>
<li>DXP Enterprises Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXPE#NASDAQ">DXPE</a>) gained 18.7% to $60.45 following strong quarterly results.</li>
<li>Century Aluminum Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENX#NASDAQ">CENX</a>) gained 17.7% to $20.66 following upbeat quarterly earnings.</li>
<li>Payoneer Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYO#NASDAQ">PAYO</a>) climbed 16% to $9.88 after the company reported better-than-expected quarterly EPS and sales and raised its FY24 revenue guidance.</li>
<li>Cushman &amp; Wakefield PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWK#NYSE">CWK</a>) gained 13.2% to $14.88 after the company reported better-than-expected quarterly adjusted EPS results.</li>
<li>Ingredion Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) rose 12.6% to $150.97 following upbeat earnings.</li>
<li>Primoris Services Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRIM#NYSE">PRIM</a>) gained 10.5% to $71.11 following strong quarterly earnings.</li>
<li>Powell Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWL#NASDAQ">POWL</a>) rose 9.1% to $293.34.</li>
<li>Cummins Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) gained 8.7% to $353.91 after the company reported better-than-expected third-quarter financial results.</li>
<li>Nomura Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) rose 7.3% to $5.64 following second-quarter results.</li>
<li>Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) gained 6.8% to $149.00 after the company reported better-than-expected quarterly financial results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41744659/jim-cramer-says-he-cant-recommend-this-major-automaker-ceva-is-way-too-high">Jim Cramer Says He Can&#8217;t Recommend This Major Automaker, Ceva Is &#8216;Way Too High&#8217;</a></li>
</ul>

Intraday Update

Markets

Movers

Trading Ideas

ALAB

ARIS

CENX

DXPE

GOGO

INGR

LIND

PAYO

PLTR

POWL

PRIM

UFPT

VMEO

Emerson Electric Posts Better-Than-Expected Results, Joins Palantir Technologies, DXP Enterprises, Cummins, Apollo Global Management And Other Big Stocks Moving Higher On Tuesday

Nomura Holdings shares are trading higher after the company reported Q2 financial results.

Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) reported quarterly earnings of $0.22 per share. This is a 175 percent increase over earnings of $0.08 per share from the same period last year. The company reported $3.25 billion in sales this quarter. This is a 23.88 percent increase over sales of $2.62 billion the same period last year.

Nomura Holdings Q2 EPS $0.22 Up From $0.08 YoY, Sales $3.25B Up From $2.62B YoY

ALTI

UPST

WENA

Shares of companies within the broader financial sector are trading lower amid overall market weakness as investors react to jobs data.

JP Morgan analyst Koki Sato assumes Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) from Neutral to Neutral.

Initiation

Analyst Ratings

JP Morgan Assumes Nomura Holdings to Neutral

Press Releases

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nomura Holdings, Inc. - NMR

NMR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Nomura Holdings Inc ADR and Encourages Investors to Contact the Firm

Comments

Nomura Holdings

Notizie

Ultime notizie per Nomura Holdings (NYSE:NMR) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO